Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique et Université de Strasbourg, 67000, Strasbourg, France.
Faculty of Biology and Bernstein Center Freiburg, University of Freiburg, D-79104, Freiburg, Germany.
Cell Tissue Res. 2019 Jul;377(1):21-43. doi: 10.1007/s00441-019-03003-z. Epub 2019 Feb 19.
The increasing number of individuals with comorbidities poses an urgent need to improve the management of patients with multiple co-existing diseases. Among these comorbidities, chronic pain and mood disorders, two long-lasting disabling conditions that significantly reduce the quality of life, could be cited first. The recent development of animal models accelerated the studies focusing on the underlying mechanisms of the chronic pain and depression/anxiety comorbidity. This review provides an overview of clinical and pre-clinical studies performed over the past two decades addressing the molecular aspects of the comorbid relationship of chronic pain and depression. We thus focused on the studies that investigated the molecular characteristics of the comorbid relationship between chronic pain and mood disorders, especially major depressive disorders, from the genetic and epigenetic point of view to key neuromodulators which have been shown to play an important role in this comorbidity.
越来越多的合并症患者迫切需要改善多种共存疾病患者的管理。在这些合并症中,慢性疼痛和情绪障碍是两种长期致残的疾病,它们显著降低了生活质量,可以首先被提及。最近动物模型的发展加速了对慢性疼痛和抑郁/焦虑合并症潜在机制的研究。本综述概述了过去二十年中进行的临床和临床前研究,这些研究涉及慢性疼痛和抑郁共病关系的分子方面。因此,我们专注于从遗传和表观遗传的角度研究慢性疼痛和情绪障碍(尤其是重性抑郁症)之间共病关系的分子特征的研究,以及已显示在这种共病中起重要作用的关键神经调节剂。